Key result
Mitochondrial dysfunction in diabetic cardiomyopathy contributes to arrhythmogenesis through mechanisms involving oxidative stress, energy deficiency, and cardiac fibrosis.
Why the study?
Diabetic cardiomyopathy increases the risk of cardiac arrhythmia and sudden cardiac death, but the underlying mechanisms remain incompletely understood.
Mitochondrial dysfunction plays a key role in the generation and maintenance of cardiac arrhythmias in diabetic hearts, suggesting mitochondria as a potential therapeutic target.
Mitochondrial-targeted therapies merit exploration in diabetic cardiomyopathy; leaves open validation in prospective trials before any practice change.
There is increasing evidence that diabetic cardiomyopathy increases the risk of cardiac arrhythmia and sudden cardiac death. While the detailed mechanisms remain incompletely understood, the loss of mitochondrial function, which is often observed in the heart of patients with diabetes, has emerged as a key contributor to the arrhythmogenic substrates. In this mini review, the pathophysiology of mitochondrial dysfunction in diabetes mellitus is explored in detail, followed by descriptions of several mechanisms potentially linking mitochondria to arrhythmogenesis in the context of diabetic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Song et al. (2018) conducted a review in Diabetic Cardiomyopathy and Cardiac Arrhythmia. Mitochondrial dysfunction in diabetic cardiomyopathy contributes to arrhythmogenesis through mechanisms involving oxidative stress, energy deficiency, and cardiac fibrosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: